NANOBIOTIX SA - ADR (NBTX) Stock News

USA - NASDAQ:NBTX - US63009J1079 - ADR

27.3 USD

+6.33 (+30.19%)

Last: 10/8/2025, 7:04:40 PM

28.5 USD

+1.2 (+4.4%)

After Hours: 10/8/2025, 7:04:40 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NBTX Latest News, Press Relases and Analysis

All

Press Releases

10 hours ago - By: Benzinga - Mentions: GSRT DGNX PLG CENX ...

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday

6 days ago - By: Benzinga - Mentions: TSHA EMPG

Top 2 Health Care Stocks That May Keep You Up At Night This Month

7 days ago - By: Nanobiotix S.A.

NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage

7 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

7 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

8 days ago - By: Nanobiotix S.A.

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025

8 days ago - By: Nanobiotix S.A.

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

8 days ago - By: Nanobiotix S.A.

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

9 days ago - By: Nanobiotix S.A.

NANOBIOTIX annonce de nouveaux résultats de Phase 1 qui continuent de confirmer le potentiel de JNJ-1900 (NBTXR3), avec un anti-PD-1, en tant que potentielle nouvelle option thérapeutique de première ou deuxième ligne ou plus dans le CETEC R/M naïf ou

9 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC

9 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC

21 days ago - By: Nanobiotix S.A.

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

21 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

21 days ago - By: Nanobiotix S.A.

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

a month ago - By: Nanobiotix S.A.

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

a month ago - By: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company

a month ago - By: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company

a month ago - By: Nanobiotix S.A.

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment

a month ago - By: Nanobiotix S.A.

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: Nanobiotix S.A.

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: Nanobiotix S.A.

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

a month ago - By: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company

a month ago - By: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company

3 months ago - By: Nanobiotix S.A.

NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une demande d’un nouveau brevet de composition de matière pour JNJ-1900 (NBTXR3)

3 months ago - By: Nanobiotix S.A.

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)

3 months ago - By: Nanobiotix S.A.

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)

4 months ago - By: Nanobiotix S.A.

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

4 months ago - By: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company